Study looks at tau proteins to understand Alzheimer's disease

02/17/2009 | PhysOrg.com

German researchers used nuclear magnetic resonance spectroscopy to study the structural properties of the tau protein in neurons of patients with Alzheimer's disease. They were able to identify which modules of the tau protein do not bind to microtubules, preventing the growth of nerve cell endings. The researchers say the tau protein can be used as a pharmaceutical target and that they are planning to study possible inhibitors that could interact with tau to avoid fibril formation.

View Full Article in:

PhysOrg.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN